Greenlight Plus Study: Approaches to Early Childhood Obesity Prevention

Sponsor
Vanderbilt University Medical Center (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT04042467
Collaborator
Patient-Centered Outcomes Research Institute (Other), Duke University (Other), University of North Carolina, Chapel Hill (Other), Stanford University (Other), NYU Langone Health (Other), University of Miami (Other)
900
6
2
53
150
2.8

Study Details

Study Description

Brief Summary

A randomized controlled trial enrolling 900 parent-infant dyads (English and Spanish speaking) comparing Greenlight (control), a behavioral intervention focusing on nutrition, physical activity, media use, and sleep as compared to Greenlight Plus (intervention) which includes the above materials plus a health information technology (HIT) intervention aimed at supporting family goal-setting and behavior change during well-child checks throughout the first 2 years of life.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Greenlight Plus
  • Behavioral: Greenlight
N/A

Detailed Description

The investigators propose a randomized trial to compare the effectiveness of two different approaches to early childhood obesity prevention in children 0-2 years of age. The investigators will randomize 900 parent-infant dyads, recruited from six newborn nurseries/primary care clinics. The participating organizations are part of both CORNET, a national practice-based research network of pediatric residency primary care practices supported by the Academic Pediatric Association (APA), and PCORnet, the national research network supported by PCORI. In the nursery or at the first newborn clinic visit, eligible families will be consented and randomized to one of two arms. In Arm 1 ("Greenlight"), during each of the recommended well child visits from 0-24 months, pediatric residents, trained in clear health communication skills and shared goal-setting, will use the Greenlight Toolkit of low literacy, age-specific, parent education booklets to promote healthy family behaviors and obesity prevention. In Arm 2 ("Greenlight Plus"), families will receive the Greenlight intervention plus a health information technology (HIT) intervention aimed at supporting family goal-setting and behavior change. This design allows us to determine if HIT and the asynchronous support it provides between well-child visits can promote additional behavior change and obesity prevention.

Specific Aims & Hypotheses (H) include:

Aim 1: Compare the effectiveness of the 2 arms on weight-for-length and other weight measures through age 2.

H1: Arm 2 will be significantly better than Arm 1 in supporting healthy child weight-for-length trajectory over 2 years;

Aim 2: Compare the effectiveness of the two approaches on parent-reported outcomes, including child feeding and physical activity behaviors, parent feeding beliefs and behaviors, media use, and quality of doctor-patient communication.

H2: Arm 2 will be significantly better at improving parent-reported health behaviors.

Aim 3: Examine differences in main outcomes by social determinants, including race/ethnicity, language, health literacy.

H3: A literacy- and culturally-sensitive approach to obesity prevention will result in equal subgroup improvements.

Aim 4: To compare weight-for-length trajectory over 2 years in both intervention arms with a non-enrolled comparison group, using data from the PCORnet Common Data Model at participating sites.

H4: PCORnet analysis will reveal the benefit of both Greenlight approaches (Arms 1 and 2) compared to before Greenlight intervention implementation and the added benefit of Arm 2 (Greenlight Plus) over other approaches.

Study Design

Study Type:
Interventional
Actual Enrollment :
900 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Investigator, Outcomes Assessor)
Masking Description:
All Greenlight Plus personnel that are in a position to change the study protocol or its implementation in study participants should be blinded to information that may allow them to do so, from when the study starts until the study ends, with specific exceptions. This means that all investigators and study staff should be blinded to study data aggregated by study arm that have the potential to impact the study's outcome. The study statistician and programmers s/he designates will be unblinded to post-randomization outcome, mediator, moderator and process data for the purposes of generating DSMB reports. The study statistician will remain objective when carrying out the activities of conducting the trials - preparing randomization schemes, processing of the data, cleaning and editing the data, preparation of analyses/reports of outcome, mediator, moderator and blinded process data, and transmitting those data to the DSMB.
Primary Purpose:
Prevention
Official Title:
Greenlight Plus Study: A Randomized Study of Approaches to Early Childhood Obesity Prevention
Actual Study Start Date :
Oct 30, 2019
Anticipated Primary Completion Date :
Sep 30, 2023
Anticipated Study Completion Date :
Mar 30, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Greenlight Plus

Families will receive the Greenlight intervention plus a health information technology (HIT) intervention aimed at supporting family goal-setting and behavior change. This design allows us to determine if HIT and the asynchronous support it provides between well-child visits can promote additional behavior change and obesity prevention.

Behavioral: Greenlight Plus
Families randomized to the Greenlight Plus arm will receive a HIT intervention starting at the newborn clinic visit. During the newborn visit, these families will receive basic instructions on how to access the Greenlight technology platform, which includes the iOTA text-messaging application and a website (usable on desktop or mobile platform). Families will receive text messages and goal-setting over the first 2 years of the child's life.

Behavioral: Greenlight
All residents and families seen in the participating clinics will receive the basic Greenlight materials.

Active Comparator: Greenlight

During each of the recommended well child visits from 0-24 months, pediatric residents, trained in clear health communication skills and shared goal-setting, will use the Greenlight Toolkit of low literacy, age- specific, parent education booklets to promote healthy family behaviors and obesity prevention.

Behavioral: Greenlight
All residents and families seen in the participating clinics will receive the basic Greenlight materials.

Outcome Measures

Primary Outcome Measures

  1. Child weight for length trajectory [Baseline to 24 months]

Secondary Outcome Measures

  1. Child BMI Z-score trajectory [Baseline to 24 months]

  2. Child weight-for-length z-score trajectory [Baseline to 24 months]

  3. Child overweight and/or obesity [at 24 months]

    Outcome defined by CDC or WHO standards

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A to 21 Days
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
For this study, eligible caregiver/infant dyads will be those with:
  1. an English- or Spanish-speaking parent/legal guardian,

  2. infant born in the newborn nursery with plans to have care in the local clinic OR presenting in that clinic for the first newborn visit (1-21 days of life),

  3. attendance at first newborn clinic visit

  4. no plans to leave the clinic within 2 years

  5. Completion of baseline data collection (survey data, child weight and length measures prior to randomization).

  6. Own a smartphone with access to data services

Exclusion Criteria:
Infant exclusion criteria:
  1. born prior to 34 weeks gestation or birth weight <1500 grams; weight <3rd %tile at enrollment (World Health Organization growth curves); or

  2. any chronic medical problem that may affect weight gain (e.g., metabolic disease, uncorrected congenital heart disease, renal disease, high-calorie formula; cleft palate; Down syndrome).

Caregiver exclusion criteria include:
  1. <18 years old;

  2. serious mental or neurologic illness that impairs ability to consent/participate;

  3. poor visual acuity (corrected vision worse than 20/50 with Rosenbaum Screener).

Contacts and Locations

Locations

Site City State Country Postal Code
1 Stanford University Stanford California United States 94305
2 University of Miami Coral Gables Florida United States 33146
3 New York University New York New York United States 10003
4 University of North Carolina Chapel Hill North Carolina United States 27599
5 Duke University Durham North Carolina United States 27708
6 Vanderbilt University Medical Center Nashville Tennessee United States 37203-2494

Sponsors and Collaborators

  • Vanderbilt University Medical Center
  • Patient-Centered Outcomes Research Institute
  • Duke University
  • University of North Carolina, Chapel Hill
  • Stanford University
  • NYU Langone Health
  • University of Miami

Investigators

  • Principal Investigator: Russell Rothman, MD, MPP, Vanderbilt University Medical Center
  • Principal Investigator: William Heerman, MD, MPH, Vanderbilt University Medical Center
  • Principal Investigator: Eliana Perrin, MD, MPH, Duke University
  • Principal Investigator: Kori Flower, MD, MS, MPH, University of North Carolina, Chapel Hill
  • Principal Investigator: Lee Sanders, MD, MPH, Stanford University
  • Principal Investigator: H. Shonna Yin, MD, MS, NYU School of Medicine, NYU Langone Health
  • Principal Investigator: Alan Delamater, PhD, University of Miami

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Bill Heerman, Assistant Professor, Internal Medicine and Pediatrics, Vanderbilt University Medical Center
ClinicalTrials.gov Identifier:
NCT04042467
Other Study ID Numbers:
  • 190311
First Posted:
Aug 2, 2019
Last Update Posted:
Oct 5, 2021
Last Verified:
Oct 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 5, 2021